# MoMelan Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/momelan-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Cambridge, US
- Website: www.momelan.com
- Total disclosed funding: $4.8M
- Latest round: Series A (Jul 18, 2011)
- Investors on record: 4

## About

MoMelan Technologies, Inc. is a technology company that specializes in innovative solutions for the food and medical sectors, providing advanced products and services to diverse global markets.MoMelan Technologies, Inc. was founded in 2009 in Cambridge, US, focusing on technological advancements in the food and medical industries. The company has facilitated 5 deals, with its most recent acquisition by Kinetic Concepts, Inc. occurring on December 18, 2012. It has raised a total of USD 1.910 mn through its SERIES A funding round, with investors including BioVentures Investors. The current valuation of MoMelan Technologies, Inc. is USD 9.506 mn.MoMelan Technologies, Inc. specializes in providing advanced technological solutions primarily in the food and medical sectors. The company's core offerings include high-quality food products, precision medical equipment, and innovative printing technologies designed for industrial applications. These products aim to meet the needs of a diverse clientele, including healthcare institutions, food service companies, and manufacturing sectors across various global markets such as the United Kingdom, Canada, and the United States. MoMelan's medical solutions are tailored for emergency rooms and healthcare providers, while its food products cater to institutional clients like hospitals and catering services. The company emphasizes quality and reliability, ensuring that all products adhere to stringent industry standards since its establishment in 2009.MoMelan Technologies, Inc. generates revenue through a structured model that includes direct sales to businesses and institutions, focusing on B2B transactions. Their clients typically include hospitals, food service providers, and industrial manufacturers, establishing long-term partnerships that facilitate ongoing supply agreements. The company’s flagship products, which include proprietary medical devices and specialized food items, are offered at competitive pricing intended to reflect the high quality and advanced technology embedded in their offerings.MoMelan Technologies, Inc. is focused on expanding its product offerings and geographical presence. Upcoming products designed for the medical and food sectors are expected to be launched in the next few years, targeting key regions such as Europe and Asia by 2025. Recent funding from the SERIES A round will be strategically utilized to support these initiatives, enhancing product development and market entry strategies.

## Funding rounds

- Series A, Jul 18, 2011, $1.9M — BioVentures Investors
- Series A, May 13, 2011, $2.9M — BioVentures Investors, LaunchCapital, Life Science Angels, Inc., Mass Medical Angels

## Investors

- BioVentures Investors (https://capitalatlas.ai/funds/bioventures-investors) — Series A
- LaunchCapital (https://capitalatlas.ai/funds/launchcapital) — Series A
- Life Science Angels, Inc. — Series A
- Mass Medical Angels — Series A